What are the risk factors for oral cavity cancer?
The main recognised risk factors for oral cavity cancer are chewing betel quid / areca nut (with or without tobacco) — IARC Group 1 carcinogen, smokeless tobacco products: gutka, khaini, zarda, snuff, toombak, iqmik and cigarette, bidi or cigar smoking. Risks differ by region: India has a distinctive exposure pattern, so a patient's country of residence is part of the risk assessment. Having a risk factor does not mean a person will develop cancer.
In detail
Risk factors are probabilistic. Many patients have no obvious exposure, and most people with an exposure never develop a head and neck tumour. Tell your clinician about all tobacco, areca nut, alcohol, occupational and viral exposures, because this information changes follow-up planning.
- Chewing betel quid / areca nut (with or without tobacco) — IARC Group 1 carcinogen
- Smokeless tobacco products: gutka, khaini, zarda, snuff, toombak, iqmik
- Cigarette, bidi or cigar smoking
- Heavy alcohol use, with a multiplicative effect when combined with tobacco
- Chronic mechanical irritation from a sharp tooth or ill-fitting denture
- Oral potentially malignant disorders: leukoplakia, erythroplakia, oral submucous fibrosis
- Prior head and neck cancer and, rarely, immunosuppression
What this means in practice: this answer is part of the “Prevention & risk” section of the Oral Cavity Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.
Other common questions about oral cavity cancer
- What is oral cavity cancer?Understanding the disease
- Where in the world is oral cavity cancer most common?Understanding the disease
- What are the early signs of oral cavity cancer?Symptoms & diagnosis
- How is oral cavity cancer diagnosed and staged?Symptoms & diagnosis
- What are the treatment options for oral cavity cancer?Treatment
- What is the prognosis for oral cavity cancer?Prognosis & follow-up
Sources for this answer
- Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022
- Oral cancer burden and mortality in India: a GLOBOCAN 2022 analysis with regional comparison
- Smokeless Tobacco and Oral Cancer in Global Perspective
- Head and neck cancer: a comprehensive review of epidemiology, global burden and advances in radiotherapy
Need an opinion on your own case?
International patients can request a preliminary review based on pathology and imaging before travelling to China.
How the pathway works Send an enquiryMedical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.